Naltrexone Hydrochloride Tablet, Film Coated
FDA Label NDC 68084-291

39 label sections · Submitted to the FDA by American Health Packaging · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by American Health Packaging for the product Naltrexone Hydrochloride (NDC 68084-291). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, pharmacodynamic actions, pharmacokinetics, other, hepatic and renal impairment, clinical trials, indications and usage, contraindications, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package/Label Display Panel – Carton - 50 Mg

NDC 68084- 291-21

Naltrexone
Hydrochloride
Tablets USP

50 mg

30 Tablets (3 x 10) Rx Only

Each Tablet Contains:
Naltrexone Hydrochloride USP .............................. 50 mg

Usual Dosage: See full prescribing information.

Store at 20° to 25°C (68° to 77°F); excursions permitted between
15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].

FOR YOUR PROTECTION: Do not use if blister is torn or broken.

The drug product contained in this package is from
NDC # 0406-1170, SpecGx LLC.

Distributed by: American Health Packaging, Columbus, Ohio 43217

029121
0229121/0624

Package/Label Display Panel – Blister - 50 Mg

Naltrexone
Hydrochloride
Tablet USP
50 mg

* Please review the disclaimer below.